X

Trial Profile

The Effect of BMS-986165 on the Pharmacokinetics of a Combined Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Deucravacitinib (Primary) ; Ethinylestradiol/norethisterone
Indications Autoimmune disorders; Inflammatory bowel diseases; Plaque psoriasis; Psoriasis; Systemic lupus erythematosus
Focus Pharmacokinetics
Sponsors Bristol-Myers Squibb

Most Recent Events

15 Feb 2018 Status changed from recruiting to completed.
25 Oct 2017 Planned number of patients changed from 20 to 24.
25 Oct 2017 Planned End Date changed from 22 Nov 2017 to 30 Nov 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com